Showing results (31-40 of 46) with videos related to
Sort By:
Pageof 5
Tissue Antigens|January 30, 2007
Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypesK Wiencke, T H Karlsen, K M Boberg, et al.Gut|October 16, 2002
Patients with small duct primary sclerosing cholangitis have a favourable long term prognosisE Björnsson, K M Boberg, S Cullen, et al.Journal of Hepatology|March 29, 2000
Cholangiocarcinoma in primary sclerosing cholangitis: K-ras mutations and Tp53 dysfunction are implicated in the neoplastic developmentK M Boberg, E Schrumpf, A Bergquist, et al.Genes and Immunity|February 16, 2007
Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitisT H Karlsen, K M Boberg, M Vatn, et al.Journal of Crohn'S & Colitis|November 19, 2013
Colectomy for patients with ulcerative colitis and primary sclerosing cholangitis - what next?M Block, K K Jørgensen, T Oresland, et al.Gut|July 17, 2001
Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitisS A Mitchell, J Grove, A Spurkland, et al.Scandinavian Journal of Gastroenterology|November 1, 2002
Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentationK M Boberg, A Bergquist, S Mitchell, et al.Scandinavian Journal of Gastroenterology|August 10, 2001
The HLA-DR3,DQ2 heterozygous genotype is associated with an accelerated progression of primary sclerosing cholangitisK M Boberg, A Spurkland, G Rocca, et al.Genes and Immunity|March 11, 2005
Association analysis of the 1858C>T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseasesM K Viken, S S Amundsen, T K Kvien, et al.Alimentary Pharmacology & Therapeutics|January 7, 2012
High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasiaL Lindström, K M Boberg, O Wikman, et al.Pageof 5